Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials

British Journal of Psychiatry

Volumn 193, Issue 2, 2008, Pages 101-107

  Álvarez Jiménez, Mario ^a,b,c   Hetrick, Sarah E ^a   González Blanch, César ^b   Gleeson, John F ^a   McGorry, Patrick D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c ORYGEN RESEARCH CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL TRIAL; COGNITIVE THERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FOLLOW UP; GROUP THERAPY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; NUTRITIONAL COUNSELING; OUTCOME ASSESSMENT; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; HUMANS; OBESITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 49149113649     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.107.042853     Document Type: Review

References (51)

1. Green AI, Patel JK, Goisman RM, Allison DB, Blackburn G. Weight gain from novel antipsychotic drugs: need for action. Gen Hosp Psychiatry 2000; 22: 224-35.
2. Álvarez-Jiménez M, González-Blanch C, Crespo-Facorro B, Hetrick S, Rodriguez-Sanchez JM, Perez-Iglesias R, Vázquez-Barquero JL. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal. CNS Drugs in press.
3. Zipursky RB, Gu H, Green AI, Perkins DO, Tohen MF, McEvoy JP, Strakowski SM, Sharma T, Kahn RS, Gur RE, Tollefson GD, Lieberman JA. Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry 2005; 187: 537-43.
4. Wirshing DA. Schizophrenia and obesity: impact of antipsychotic medications. J Clin Psychiatry 2004; 65 (suppl 18): S13-26.
5. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database Syst Rev 2007; (1): CD005148.
6. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In Systematic Reviews in Health Care: Meta-Analysis in Context (eds M Egger, GD Smith & D Altman): 285-312. WileyBlackwell, 2001.
7. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
8. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
9. Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
10. Light RJ, Pillemer DB. Summing Up: The Science of Reviewing Research: 13-31. Harvard University Press, 1984.
11. Egger M, Smith GD, Phillips AN. Meta-analysis. Principles and procedures. BMJ 1997; 315: 1533-7.
12. Centorrino F, Wurtman JJ, Duca KA, Fellman VH, Fogarty KV, Berry JM, Guay DM, Romeling M, Kidwell J, Cincotta SL, Baldessarini RJ. Weight loss in overweight patients maintained on atypical antipsychotic agents. Int J Obes 2006; 30: 1011-6.
13. Feeney L, Dempsey J, Moynihan F, Barry S. Changes in body mass indices of patients with schizophrenia 3 years following the introduction of a weight management programme. Ir Med J 2003; 96: 276-7.
14. Kalarchian MA, Marcus MD, Levine MD, Haas GL, Greeno CG, Weissfeld LA, Qin L. Behavioral treatment of obesity in patients taking antipsychotic medications. J Clin Psychiatry 2005; 66: 1058-63.
15. Klein B, Simon WE, Steele RL, Primavera LH. Reinforcement and weight loss in schizophrenics. Psychol Rep 1972; 30: 581-2.
16. Knox JM. A study of weight reducing diets in psychiatric in-patients. Br J Psychiatry 1980; 136: 287-9.
17. Ball MP, Coons VB, Buchanan RW. A program for treating olanzapine-related weight gain. Psychiatr Serv 2001; 52: 967-9.
18. McCreadie R, Macdonald E, Blacklock C, Tilak-Singh D, Wiles D, Halliday J, Paterson J. Dietary intake of schizophrenic patients in Nithsdale, Scotland: case-control study. BMJ 1998; 317: 784-5.
19. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry 2004; 65: 471-7.
20. Sletten I, Mou B, Cazenave M, Gershon S. Effects of caloric restriction on behaviour and body weight during chloropromazine therapy Dis Nerv Syst 1967; 28: 519-22.
21. Voruganti LN, Whatham J, Bard E, Parker G, Babbey C, Ryan J, Lee S, MacCrimmon DJ. Going beyond. An adventure- and recreation-based group intervention promotes well-being and weight loss in schizophrenia. Can J Psychiatry 2006; 51: 575-80.
22. Vreeland B, Minsky S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003; 54: 1155-7.
23. Harmatz MG, Lapuc P. Behavior modification of overeating in a psychiatric population. J Consult Clin Psychol 1968; 32: 583-7.
24. Rotatori AF, Fox R, Wicks A. Weight loss with psychiatric residents in a behavioral self control program. Psychol Rep 1980; 46: 483-6.
25. Brown C, Goetz J, Van Sciver A, Sullivan D, Hamera E. A psychiatric rehabilitation approach to weight loss. Psychiatr Rehabil J 2006; 29: 267-73.
26. Archie S, Wilson JH, Osborne S, Hobbs H, McNiven J. Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry 2003; 48: 628-32.
27. McCreadie RG, Kelly C, Connolly M, Williams S, Baxter G, Lean M, Paterson JR. Dietary improvement in people with schizophrenia. Randomised controlled trial. Br J Psychiatry 2005; 187: 346-51.
28. Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005; 26: 661-76.
29. Álvarez-Jiménez M, González-Blanch C, Vázquez-Barquero JL, Pérez-Iglesias R, Martínez- García O, Pérez-Pardal T, Ramírez-Bonilla ML, Crespo-Facorro B. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients. A randomized controlled trial. J Clin Psychiatry 2006; 67: 1253-60.
30. Brar JS, Ganguli R, Pandina G, Turkoz I, Berry S, Mahmoud R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005; 66: 205-12.
31. Khazaal Y, Fresard E, Rabia S, Chatton A, Rothen S, Pomini V, Grasset F, Borgeat F, Zullino D. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res 2007; 91: 169-77.
32. Kwon JS, Choi JS, Bahk WM, Yoon Kim C, Hyung Kim C, Chul Shin Y, Park BJ, Geun Oh C. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder. A 12-week randomized controlled clinical trial. J Clin Psychiatry 2006; 67: 547-53.
33. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O'Hanlon K, Griver K, Sirkin A, Jeste DV. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006; 86: 36-44.
34. Weber M, Wyne K. A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophr Res 2006; 83: 95-101.
35. Evans S, Newton R, Higgins S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust N Z J Psychiatry 2005; 39: 479-86.
36. Littrell KH, Hilligoss NM, Kirshner CD, Petty RG, Johnson CG. The effects of an educational intervention on antipsychotic-induced weight gain. J Nurs Scholarsh 2003; 35: 237-41.
37. Scocco P, Longo R, Caon F. Weight change in treatment with olanzapine and a psychoeducational approach. Eat Behav 2006; 7: 115-24.
38. Wu MK, Wang CK, Bai YM, Huang CY, Lee SD. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv 2007; 58: 544-50.
39. Pendlebury J, Bushe CJ, Wildgust HJ, Holt RIG. Long-term maintenance of weight loss in patients with severe mental illness through a behavioural treatment programme in the UK. Acta Psychiatr Scand 2007; 115: 286-94.
40. Haddock G, Lewis S, Bentall R, Dunn G, Drake R, Tarrier N. Influence of age on outcome of psychological treatments in first-episode psychosis. Br J Psychiatry 2006; 188: 250-4.
41. Coldham EL, Addington J, Addington D. Medication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand 2002; 106: 286-90.
42. Gortmaker SL, Must A, Perrin JM, Sobol AM, Dietz WH. Social and economic consequences of overweight in adolescence and young adulthood N Engl J Med 1993; 329: 1008-12.
43. McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ. Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 2006; 40: 616-22.
44. Institute of Medicine. Weighing the Options: Criteria for Evaluating Weight-Management Programs. National Academy Press, 1995.
45. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004; 161: 1334-49.
46. Juni P, Altman DG, Egger M. Systematic reviews in health care. Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-6.
47. Bradshaw T, Lovell K, Harris N. Healthy living interventions and schizophrenia: a systematic review. J Adv Nurs 2005; 49: 634-54.
48. Weiden PJ, Mackell JA, McDonnell DD. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 2004; 66: 51-7.
49. Allison DB, Mackell JA, McDonnell DD. The impact of weight gain on quality of life among persons with schizophrenia. Psychiatr Serv 2003; 54: 565-7.
50. Aronne LJ. Epidemiology, morbidity, and treatment of overweight and obesity. J Clin Psychiatry 2001; 62 (suppl 23): S13-22.
51. Crisp AH, Gelder MG, Rix S, Meltzer HI, Rowlands OJ. Stigmatisation of people with mental illnesses. Br J Psychiatry 2000; 177: 4-7.